Soluplus® as a solubilizing excipient for poorly water-soluble drugs: Recent advances in formulation strategies and pharmaceutical product features

Faculty	Pharmacy	Year:	2023
Type of Publication:	ZU Hosted	Pages:
Authors:	Staff Zu Site Abstract In Staff Site
Journal:	Journal of Drug Delivery Science and Technology Elsevier	Volume:

Keywords :	Soluplus® , , solubilizing excipient , poorly water-soluble drugs:
Abstract:	Since the emergence of Soluplus® (SOL) as a commercial graft copolymer, several publications have been issued on its promising potential as a solubilizing excipient that could promote the dissolution rate and bioavailability of several poor

Author Related Publications

Amr Selim Ahmed Ali Abu Lila, "Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production", nature, 2014 More
Fakhreldeen Soliman Ghazy Shehata, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
Amr Selim Ahmed Ali Abu Lila, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
Azza Ali Hassan Solyman, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More
Eman Gomaa Ahmed alsayed, "Treatment of pulmonary arterial hypertension by vardenafil-solid dispersion lozenges as a potential alternative drug delivery system", Elsevier, 2020 More